首页> 外文期刊>海南医科大学学报(英文版) >Effect of Bailing capsule combined with Edaravone on immune function, antioxidant function and related factors in patients with chronic obstructive pulmonary disease
【24h】

Effect of Bailing capsule combined with Edaravone on immune function, antioxidant function and related factors in patients with chronic obstructive pulmonary disease

机译:百灵胶囊联合依达拉奉对慢性阻塞性肺疾病患者免疫功能,抗氧化功能及相关因素的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To investigate the effects of Bailing capsule combined with edaravone on immune function, antioxidant function and related factors in patients with chronic obstructive pulmonary disease (COPD).Methods:160 patients with COPD who received treatment in the department of respiratory medicine of our hospital from March 2016 to March 2018 were randomly divided into control group and observation group, 80 cases in each group. Patients in the control group received edaravone treatment, while patients in the observation group received bailing capsule combined with edaravone treatment. The levels of T lymphocyte, superoxide dismutase (SOD), malondialdehyde (MDA), nitric oxide (NO), transforming growth factor-β1 (TGF-β1), tumor necrosis factor-α (TNF-α) and matrix metalloproteinase-9 (MMP-9) were measured and compared before and after treatment.Result: After treatment, the levels of CD3+, CD4+, CD4+ / CD8+, SOD and NO of patients in the control group and the observation group were significantly higher than those before treatment, while the levels of CD8+ and MDA were significantly lower than those before treatment. The change trend of the levels of T lymphocyte and antioxidant enzyme of patients in the observation group were significantly more obvious than that in the control group (P<0.05). After treatment, the serum levels of TGF-β1, TNF-α and MMP-9 of patients in the control group and the observation group decreased significantly, and the change trend of the above factors of patients in the observation group was more obvious than that in the control group (P<0.05).Conclusion: Bailing capsule combined with edaravone in the treatment of chronic obstructive pulmonary disease can significantly enhance the immune function and antioxidant function of patients and alleviate inflammation of the body. It has good clinical curative effect.
机译:目的:探讨百灵胶囊联合依达拉奉对慢性阻塞性肺疾病(COPD)患者免疫功能,抗氧化功能及相关因素的影响。方法:160例COPD患者在我院呼吸内科就诊。从2016年3月至2018年3月,随机分为对照组和观察组,每组80例。对照组患者接受依达拉奉治疗,而观察组患者接受拜耳胶囊联合依达拉奉治疗。 T淋巴细胞,超氧化物歧化酶(SOD),丙二醛(MDA),一氧化氮(NO),转化生长因子β1(TGF-β1),肿瘤坏死因子α(TNF-α)和基质金属蛋白酶9(结果:治疗后,对照组和观察组患者的CD3 +,CD4 +,CD4 + / CD8 +,SOD和NO水平明显高于治疗前;而CD8 +和MDA的水平明显低于治疗前。观察组患者T淋巴细胞和抗氧化酶水平的变化趋势明显比对照组明显(P <0.05)。治疗后,对照组和观察组患者的血清TGF-β1,TNF-α和MMP-9水平明显下降,观察组患者上述各因子的变化趋势比对照组明显。结论:百灵胶囊联合依达拉奉治疗慢性阻塞性肺疾病可以明显增强患者的免疫功能和抗氧化功能,减轻机体炎症。具有良好的临床疗效。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2018年第24期|20-23|共4页
  • 作者单位

    Respiratory Medicine Department, 81st PLA Hospital, Nanjing 210012, Jiangsu, China;

    Respiratory Medicine Department, 81st PLA Hospital, Nanjing 210012, Jiangsu, China;

    Respiratory Medicine Department, 81st PLA Hospital, Nanjing 210012, Jiangsu, China;

    Respiratory Medicine Department, 81st PLA Hospital, Nanjing 210012, Jiangsu, China;

    Respiratory Medicine Department, 81st PLA Hospital, Nanjing 210012, Jiangsu, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号